SurVeil Drug-Coated Balloon

Paclitaxel drug-coated balloon for percutaneous transluminal angioplasty of the superficial femoral and popliteal arteries; co-developed with Surmodics, with Abbott holding exclusive worldwide commercialization rights. FDA approved June 2023.

FDA approval date

June 2023